Drug Profile
Parecoxib
Alternative Names: DYNASTAT; Rayzon; SC 69124A; Xapit; YM 978Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Astellas Pharma; Pfizer
- Class Isoxazoles; Non-opioid analgesics; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Pain
Most Recent Events
- 04 Sep 2009 No development reported - Preregistration for Pain in USA (IV)
- 20 Sep 2005 Pfizer has received a non-approvable letter from the US FDA for parecoxib in Pain
- 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma